BELFIORI, GIULIO
 Distribuzione geografica
Continente #
EU - Europa 2.366
NA - Nord America 2.115
AS - Asia 1.617
SA - Sud America 212
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 39
OC - Oceania 2
Totale 6.540
Nazione #
US - Stati Uniti d'America 1.953
RU - Federazione Russa 1.116
SG - Singapore 615
IT - Italia 519
CN - Cina 489
RO - Romania 266
BR - Brasile 165
HK - Hong Kong 153
VN - Vietnam 116
DE - Germania 93
BD - Bangladesh 91
CA - Canada 82
FR - Francia 70
GB - Regno Unito 68
FI - Finlandia 48
IN - India 48
SE - Svezia 38
PL - Polonia 33
NL - Olanda 27
ES - Italia 26
MX - Messico 22
AR - Argentina 20
AT - Austria 20
JP - Giappone 19
ZA - Sudafrica 17
CR - Costa Rica 13
MY - Malesia 12
ID - Indonesia 11
TR - Turchia 11
EC - Ecuador 10
IQ - Iraq 9
JM - Giamaica 9
LT - Lituania 8
UA - Ucraina 8
PH - Filippine 7
CO - Colombia 6
CW - ???statistics.table.value.countryCode.CW??? 6
HN - Honduras 6
IE - Irlanda 6
KE - Kenya 6
PR - Porto Rico 6
BE - Belgio 5
PK - Pakistan 5
SV - El Salvador 5
IL - Israele 4
NI - Nicaragua 4
PY - Paraguay 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
GP - Guadalupe 3
HU - Ungheria 3
MA - Marocco 3
NP - Nepal 3
TW - Taiwan 3
AU - Australia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
IR - Iran 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
TN - Tunisia 2
UY - Uruguay 2
VC - Saint Vincent e Grenadine 2
VE - Venezuela 2
BB - Barbados 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
OM - Oman 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
Totale 6.358
Città #
Singapore 361
Ashburn 290
San Jose 234
Moscow 216
Hong Kong 151
Dallas 123
Milan 114
New York 87
Council Bluffs 82
Beijing 76
Shanghai 67
Los Angeles 65
Santa Clara 58
Phoenix 56
Rome 49
Hefei 44
Ho Chi Minh City 39
Orem 39
Lauterbourg 37
Boardman 36
São Paulo 29
Hanoi 23
Montreal 23
Chicago 22
Helsinki 22
Nuremberg 22
Warsaw 22
Munich 21
Atlanta 19
Frankfurt am Main 19
Naples 19
Buffalo 18
Stockholm 18
Chennai 17
Denver 17
Toronto 17
Brooklyn 16
Poplar 15
Brescia 14
Boston 13
Johannesburg 13
Lappeenranta 13
Turku 13
Pisa 12
Amsterdam 11
Cesano Boscone 11
London 11
Seattle 11
Tokyo 11
Vienna 11
Houston 10
San José 10
Guangzhou 9
Manchester 9
Mexico City 9
North Bergen 9
Assago 8
Charlotte 7
Florence 7
Memphis 7
Omaha 7
Ottawa 7
Perugia 7
Pune 7
Rio de Janeiro 7
St Louis 7
Tianjin 7
Bagnatica 6
Bologna 6
Brasília 6
Dublin 6
Falkenstein 6
Hangzhou 6
Kingston 6
Las Vegas 6
Miami 6
Miano 6
Mumbai 6
Philadelphia 6
Turin 6
Willemstad 6
Brussels 5
Calgary 5
Carlsbad 5
Figino 5
Guayaquil 5
Jiaxing 5
Providence 5
Querétaro 5
San Francisco 5
Shenzhen 5
The Bronx 5
The Dalles 5
Verdellino 5
Ankara 4
Baghdad 4
Belo Horizonte 4
Bexley 4
Buenos Aires 4
Cagliari 4
Totale 3.034
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 375
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 212
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 208
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 198
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 156
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 149
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 149
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 141
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 134
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 134
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 133
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 126
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 126
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 126
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 124
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 124
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 123
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 123
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 123
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 121
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 121
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 121
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 119
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 117
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 116
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 115
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 114
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 113
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 112
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 110
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 109
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a “Biological R2 Definition” 107
Risk factors for the occurrence of ampullary tumors: A case-control study 104
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy 100
Surgical Planning for “Borderline Resectable” and “Locally Advanced” Pancreatic Cancer During Open Pancreatic Resection 98
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 97
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease 96
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 94
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 89
Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature 88
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength 88
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 85
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer 83
ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist? 83
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 81
Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study 79
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 76
Clinical features and evolution of paraduodenal (groove) pancreatitis: A multicenter study 75
Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground 75
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 69
Preoperative prediction of metastatic body-tail peripancreatic lymph nodes as a guide for surgical decision-making in pancreatic neck ductal adenocarcinoma 67
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 59
Response to ‘Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer’ 49
Endoscopic ultrasound-guided gallbladder drainage in acute cholecystitis with contained perforation: a prospective cohort study 45
Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-institutional Analysis 40
Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment 39
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study 36
Actual Five-year Survival After Neoadjuvant Therapy and Resection for Localized Pancreatic Ductal Adenocarcinoma 31
Clinico-pathological features and prognosis of mixed-IPMNs with a focal involvement of the main pancreatic duct 26
ASO Visual Abstract: Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment 24
Real life management of intraductal papillary mucinous neoplasms of the pancreas: Final data from the prospective Italian pancreatic cysts (PANCY) registry 20
ASO Author Reflections: Early Disease-Related Mortality After Neoadjuvant Therapy and Radical Resection for Pancreatic Ductal Adenocarcinoma—The Biological Burden Beyond Resectability 18
Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis 18
Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume 14
IgG4-related autoimmune pancreatitis mimicking a degenerating intraductal papillary mucinous neoplasm 11
Neoadjuvant Chemotherapy With or Without Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma 4
Totale 6.540
Categoria #
all - tutte 24.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/202353 3 2 1 0 2 7 11 10 0 0 10 7
2023/2024237 3 12 27 31 23 39 11 22 3 0 31 35
2024/20251.160 62 20 41 66 73 77 391 103 123 51 66 87
2025/20263.928 220 192 129 418 379 136 330 359 1.052 242 256 215
2026/20271.160 122 267 244 527 0 0 0 0 0 0 0 0
Totale 6.540